Fresenius Kabi AG Recalls Red Blood Cell (RBC) Exchange Sets
Published: Dec 21, 2010
The Company issued a Field Safety Corrective Action letter dated October 18, 2010 to their U.S. customers and followed up with telephone calls advising customers to examine their stock and determine if they have any affected products on hand. Customers were instructed to discontinue distributing, using, and dispensing the affected products, and return the product to Fresenius Kabi, LLC, 8635 154th Avenue, NE, Redmond, WA 98052. The consignees/customers were also instructed to notify their sub-account customers if the products were further distributed and to complete the Product Recall Response Form and fax it back to 425-242-2101.